<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03363828</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-345-15</org_study_id>
    <nct_id>NCT03363828</nct_id>
  </id_info>
  <brief_title>The Temporo-spatial Dynamics of Genital Tract Microbiota</brief_title>
  <official_title>The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in IVF-Freeze All Patients Treated With Estradiol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Humaidan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Statens Serum Institut</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regionshospitalet Viborg, Skive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to examine the endometrium with state of the art sequencing techniques
      to investigate the endometrial microbiota. The endometrial microbiota has been perceived to
      be sterile, however, this seems incorrect from recent studies. Thus, the primary outcome is
      to compare the rate of ascending infection from the semen to the vagina to the endometrium
      and to investigate which bacteria are capable of inhabiting these environments. Furthermore,
      cervical mucus will be obtained in order to test for immunological, microbiological and
      mechanical properties that may be involved in ascending infection. Finally, the study aim to
      characterize the temporal changes in the vaginal microbiota during estrogenic treatment with
      EstrofemÂ® or Vivelle Dot (R) for preparation of the endometrium prior to embryo transfer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">June 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of ascending infection/sharing of bacteria in the genital tract</measure>
    <time_frame>This outcome data is measured at the day of oocyte retrieval.</time_frame>
    <description>Seminal, vaginal, cervical and endometrial samples will be compared at the time of oocyte retrieval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Next generation sequencing techniques will be used to assess the vaginal microbiota.I.e. measure of relative abundances</measure>
    <time_frame>Examined longitudinally throughout the segmentation cycle. The estimated time to event is 40 days from oocyte retrieval until frozen embryo transfer following a strict protocol.</time_frame>
    <description>Vaginal microbiota changes throughout the preparation of the endometrium for frozen embryo transfer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>qPCR to assess the vaginal microbiota. I.e. a quantitative measure Copies/mL.</measure>
    <time_frame>Examined longitudinally throughout the segmentation cycle. The estimated time to event is 40 days from oocyte retrieval until frozen embryo transfer following a strict protocol.</time_frame>
    <description>Vaginal microbiota changes throughout the preparation of the endometrium for frozen embryo transfer.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>Normal microbiota</arm_group_label>
    <description>Based on qPCR and Next gen sequencing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abnormal microbiota</arm_group_label>
    <description>Based on qPCR and Next gen sequencing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clindamycin Oral Tablet</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Abnormal microbiota</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Vaginal, cervical and endometrial. Also semen of patients with male partner.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Infertile couples attending IVF treatment and referred to a segmentation protocol.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients in IVF Freeze-all/segmentation treatment protocol.

          -  Written informed consent.

        Exclusion Criteria:

          -  Uterine malformations

          -  HIV, Hepatitis B or C positivity. HPV CIN 2 or higher. Chlamydia trachomatis
             positivity.

          -  Any uncontrolled concomitant disease (e.g. uncontrolled diabetes, uncontrolled
             hypertension etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Fertility Clinic Skive</name>
      <address>
        <city>Skive</city>
        <zip>7800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thor Haahr, Bsc</last_name>
      <phone>+4527885402</phone>
      <email>thohaa@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Fertility Clinic, Regional Hospital of Skive</name>
      <address>
        <city>Skive</city>
        <zip>7800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter S Humaidan, MD</last_name>
      <phone>+45 89 27 40 13</phone>
      <email>peter.humaidan@sygehusviborg.dk</email>
    </contact>
    <contact_backup>
      <last_name>Alice T Mikkelsen, Nurse</last_name>
      <phone>+45 89 27 40 85</phone>
    </contact_backup>
    <investigator>
      <last_name>Peter S Humaidan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2017</study_first_submitted>
  <study_first_submitted_qc>December 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Regionshospitalet Viborg, Skive</investigator_affiliation>
    <investigator_full_name>Peter Humaidan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clindamycin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Part of PhD project. Data will appear in the thesis and subsequent publications.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

